Stockscreener 앱 받기
6.85
0.29%
-0.02
시간 외 거래:
6.82
-0.03
-0.44%
전일 마감가:
$6.87
열려 있는:
$6.9715
하루 거래량:
26,618
Relative Volume:
0.26
시가총액:
$393.94M
수익:
$154.57M
순이익/손실:
$15.07M
주가수익비율:
25.37
EPS:
0.27
순현금흐름:
$10.92M
1주 성능:
+3.32%
1개월 성능:
+3.79%
6개월 성능:
+16.30%
1년 성능:
+31.23%
1일 변동 폭
$6.78
$6.9715
1주일 범위
$6.78
$7.0568
52주 변동 폭
$4.74
$9.155
Kamada Ltd Stock (KMDA) Company Profile
KMDA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
6.85 | 381.26M | 154.57M | 15.07M | 10.92M | 0.27 |
|
HLN
Haleon Plc Adr
|
11.35 | 50.14B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
168.63 | 72.38B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.79 | 4.22M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 45.51B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.45B | 16.54B | -1.64B | 749.00M | -1.45 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 개시 | The Benchmark Company | Buy |
| 2024-07-03 | 개시 | Stifel | Buy |
| 2018-02-02 | 개시 | Chardan Capital Markets | Buy |
Kamada Ltd 주식(KMDA)의 최신 뉴스
Alpha-1 Antitrypsin Deficiency Market: Epidemiology, - openPR.com
Kamada (NASDAQ:KMDA) Stock Crosses Below 200 Day Moving Average – What’s Next? - Defense World
Kamada (NASDAQ:KMDA) Stock Rating Upgraded by Wall Street Zen - Defense World
Kamada's (TLV:KMDA) Solid Earnings Are Supported By Other Strong Factors - simplywall.st
HC Wainwright Issues Optimistic Outlook for Kamada Earnings - Defense World
Sidoti Csr Has Optimistic Outlook of Kamada FY2025 Earnings - Defense World
Kamada’s (KMDA) Buy Rating Reiterated at Benchmark - Defense World
Kamada Ltd. (NASDAQ:KMDA) Q1 2025 Earnings Call Transcript - MSN
Is Kamada (KMDA) Stock Undervalued Right Now? - Yahoo Finance
Kamada Ltd’s Earnings Call Highlights Strong Growth and Expansion - TipRanks
Kamada (KMDA) Receives Reiterated Buy Rating from Benchmark | KM - GuruFocus
Kamada (KMDA) Receives Reiterated Buy Rating from Benchmark | KMDA Stock News - GuruFocus
Benchmark maintains Kamada stock Buy rating with $15 target By Investing.com - Investing.com Nigeria
Kamada: Q1 Earnings Snapshot - CT Insider
Kamada Ltd (KMDA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion - Yahoo
Kamada Ltd (KMDA) Q1 2025 Earnings Call Highlights: Strong Reven - GuruFocus
Kamada Ltd. Reports Strong Q1 2025 Results - TipRanks
Kamada Q1 2025 Earnings Call Transcript - MarketBeat
Compared to Estimates, Kamada (KMDA) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Kamada Reports Strong First Quarter 2025 Financial Results with - GuruFocus
Kamada Reports Strong Q1 2025 Financial Results and Expands Plasma Operations - TipRanks
Kamada Reports Strong First Quarter 2025 Financial Results - GlobeNewswire
Inter Alpha Inhibitor Treatment Market Size in 7MM is expected - openPR.com
Kamada (KMDA) Projected to Post Quarterly Earnings on Wednesday - Defense World
Kamada (NASDAQ:KMDA) Upgraded at Sidoti - Defense World
Kamada (KMDA) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025 - GlobeNewswire
Kamada Ltd. to report Q1 2025 financial results on May 14 - Investing.com Nigeria
Kamada to Release Q1 2025 Financial Results on May 14 - TipRanks
JPMorgan Chase & Co. Invests $67,000 in Kamada Ltd. (NASDAQ:KMDA) - Defense World
Kamada Launches Post-Marketing Research Program for CYTOGAM - TipRanks
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM® - GlobeNewswire
Major Breakthrough: Kamada Initiates 10 Clinical Studies to Transform Organ Transplant CMV Treatment - Stock Titan
Geode Capital Management LLC Raises Position in Kamada Ltd. (NASDAQ:KMDA) - Defense World
Kamada Ltd expected to post earnings of 7 cents a shareEarnings Preview - TradingView
Press Release Distribution & PR Platform - ACCESS Newswire
Kamada Expands Specialty Plasma Collection Capabilities with New San Antonio Facility - citybuzz -
Kamada Expects Third Plasma Collection Site To Support Its Hyper-Immune Plasma Needs And Add Up To $10M In Annual Revenue At Full Capacity - The Globe and Mail
Renaissance Technologies LLC Lowers Holdings in Kamada Ltd. (NASDAQ:KMDA) - Defense World
Kamada Is Bringing Relief To Those With Rare And Serious ConditionsKamada (NASDAQ:KMDA) - Benzinga
Despite shrinking by ₪175m in the past week, Kamada (TLV:KMDA) shareholders are still up 21% over 3 years - simplywall.st
Kamada Ekadashi 2025: Know the date, timings, significance, puja vidhi, and more - The Indian Express
Kamada Ltd. (NASDAQ:KMDA) Short Interest Up 61.8% in March - MarketBeat
Kamada (NASDAQ:KMDA) Downgraded by StockNews.com to “Buy” - Defense World
Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders - GlobeNewswire
Kamada Ltd. announces dividend tax details By Investing.com - Investing.com Australia
Kamada Ltd. announces dividend tax details - Investing.com
Kamada Ltd (KMDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
18.36%
0.52%
자본화:
|
볼륨(24시간):